Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%

Noxopharm Ltd

NOX

ASX

Noxopharm Limited (NOX) is an innovative Australian biotech company discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance mRNA vaccines. The company utilises specialist in-house capabilities and strategic partnerships with leading researchers to build a growing pipeline of new proprietary drugs based on two technology platforms - Chroma™ (oncology) and Sofra™ (inflammation, autoimmunity, and mRNA vaccine enhancement).

Latest Posts

Line Chart with Gradient
Price
$0.105
0.005 (5%)
At Close 05/12 (AEST)
Related Companies
PATRYS LIMITED
$PAB
SYNTARA LIMITED
$SNT
GENETIC TECHNOLOGIES LIMITED
$GTG
PROTEOMICS INTERNATIONAL LABORATORIES LTD
$PIQ
PARADIGM BIOPHARMACEUTICALS LIMITED..
$PAR

Leave a Comment on NOX


Comments for NOX

    Latest Posts

    noxopharm-asx-nox-issues-500000-convertible-note-nox
    Health Care $NOX
    Noxopharm (ASX: $NOX) issues $500,000 convertible noteNew funding aims to support ongoing capital management and exploration of potential opportunities
    November 5, 2024
    noxopharm-asx-nox-releases-quarterly-activities-report-nox
    Health Care $NOX
    Noxopharm (ASX: $NOX) releases quarterly activities reportHighlights include drug development progress, financial updates, and strategic partnerships for sustained growth
    October 29, 2024
    noxopharm-asx-nox-secures-a2-1-million-funding-from-sophisticated-investors-nox
    Health Care $NOX

    Noxopharm (ASX: $NOX) secures A$2.1 million funding from sophisticated investors

    Convertible notes issued to explore future opportunities and secure R&D tax rebate

    September 27, 2024
    noxopharm-asx-nox-secures-advanced-funding-for-rd-rebate-nox
    Health Care $NOX

    Noxopharm (ASX: $NOX) secures advanced funding for R&D rebate

    Endpoints Capital provides $1.8 million secured loan agreement repayable from R&D rebate proceeds

    September 6, 2024
    noxopharm-asx-nox-progresses-novel-brain-cancer-drugs-nox
    Health Care $NOX

    Noxopharm (ASX: $NOX) progresses novel brain cancer drugs

    Chroma platform shows promising results for glioblastoma and leukaemia treatments

    September 3, 2024
    noxopharm-asx-nox-announces-encouraging-cro-67-results-in-pancreatic-cancer-studies-nox
    Health Care $NOX

    Noxopharm (ASX: $NOX) announces encouraging CRO-67 results in pancreatic cancer studies

    Innovative dual-cell therapy shows significant reduction in tumours, barrier cells, and cancer spread

    August 14, 2024
    noxopharm-asx-nox-reports-half-year-results-nox
    Health Care $NOX

    Noxopharm (ASX: $NOX) reports half year results

    Company carefully reviews expenditure and advances drug discovery and preclinical studies

    February 27, 2024

    NOX

    $NOX

    Noxopharm (ASX: $NOX) issues $500,000 convertible note

    New funding aims to support ongoing capital management and exploration of potential opportunities

    NOX

    $NOX

    Noxopharm (ASX: $NOX) releases quarterly activities report

    Highlights include drug development progress, financial updates, and strategic partnerships for sustained growth

    NOX

    $NOX

    Noxopharm (ASX: $NOX) secures A$2.1 million funding from sophisticated investors

    Convertible notes issued to explore future opportunities and secure R&D tax rebate

    NOX

    $NOX

    Noxopharm (ASX: $NOX) secures advanced funding for R&D rebate

    Endpoints Capital provides $1.8 million secured loan agreement repayable from R&D rebate proceeds

    NOX

    $NOX

    Noxopharm (ASX: $NOX) progresses novel brain cancer drugs

    Chroma platform shows promising results for glioblastoma and leukaemia treatments

    NOX

    $NOX

    Noxopharm (ASX: $NOX) announces encouraging CRO-67 results in pancreatic cancer studies

    Innovative dual-cell therapy shows significant reduction in tumours, barrier cells, and cancer spread

    NOX

    $NOX

    Noxopharm (ASX: $NOX) reports half year results

    Company carefully reviews expenditure and advances drug discovery and preclinical studies

    Related Companies
    VITA LIFE SCIENCES LIMITED..
    $VLS
    AFT PHARMACEUTICALS LIMITED
    $AFP
    PROBIOTEC LIMITED
    $PBP
    ANATARA LIFESCIENCES LTD
    $ANR
    ALTERITY THERAPEUTICS LIMITED
    $ATH

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions